glp 1 receptor agonists mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Mechanisms by which GLP-1 agonists
Description
Kahal H, Abouda G, Rigby AS, et al
Here, after metformin failure, GLP-1 receptor agonists, or SGLT-2 inhibitors are recommended as second line therapy or as third line therapy in combination

2018;9:278S-94S

In response, leading pharmas have announced massive capacity expansions: Novo Nordisk plans a $4.1 billion manufacturing facility in North Carolina ( [5] ) (opening ~2029), and Lilly has committed over $15 billion for new plants in Indiana, Wisconsin, Pennsylvania, and Alabama ( [6] ) ( [7] ) ( [8] ) ( [9] )

doi:10.1111/dom.13358 187

To our knowledge, only one study failed to prove significant differences in weight loss between treatment with liraglutide and placebo [60]
